Allergy Associates of Northern Virginia, PLLC

06/24/2024

****ATTENTION**** THE OFFICE WILL BE CLOSING EFFECTIVE JULY 31, 2024****

The practice (including all medical records and treatment vials) will be transferred to Allergy and Asthma Associates, the office of Drs. Courtney Blair, Sharon Seth, Karen Robbins and PA-Bridget Schaefer).

Please reach our to AAA as soon as possible to make an appointment.
Located: McLean and Sterling, Virginia
1360 Beverly RoadSuite 103 McLean, VA 22101
703.356.8290
www.VirginiaAllergyRelief.com

Allergy and Asthma Associates, P.C. is making efforts to accommodate a smooth transition to their practice. AAA is opening up patient hours specifically for transferring patients from Dr. Bailey's office. In addition to any open times, special office hours will be available on selected Wednesday afternoons and Friday mornings as virtual or in-person visits for transferring patients. When calling, current AANV patients should mention that they are transferring from Dr. Bailey's practice. They will schedule the AANV patients as quickly as possible with our first available provider. More details are available at www.VirginiaAllergyRelief.com

Allergy and Asthma Associates, P.C. is a medical practice located in McLean, Virginia. Meet our team of respected allergists and schedule an appointment!

05/27/2024

We are closed in observance of Memorial Day. 🇺🇸

04/24/2024

Tree pollen counts are very high levels (over 1,000 grains per cubic meter) consisting of oak, pine, sycamore, mulberry and a host of other tree species.

Grass is at moderate levels and rising quickly.

Follow your allergy action plans.

03/26/2024

How to Find Relief from Spring Allergies
Arlington allergist Sally Joo Bailey explains what triggers seasonal sniffles and what can soothe them.
March 25, 2024 Stephanie Kanowitz
https://www.arlingtonmagazine.com/spring-allergies-northern-virginia/

03/16/2024

Xhance-1st FDA approved for patients with chronic sinusitis without polyps.

Optinose (NASDAQ:OPTN) today announced the U.S. Food and Drug Administration (FDA) has approved XHANCE® (fluticasone propionate) nasal spray for the treatment of chronic rhinosinusitis without nasal polyps in patients 18 years of age and older.

03/14/2024

We are at HIGH tree pollen levels! Cottonwood, Cedar, Maple, Elm tree pollen have been releasing into the air and now the warm sunny weather is triggering Oak, Ash, Hackberry and Willow to flower and add into this mix. Be sure to follow your allergy action plans. If you don't have one, see us for a visit. Allergy immunotherapy drops (SLIT drops) are a great natural way of treating your allergies long term at home. Ask us about SLIT drops.

03/12/2024

Some helpful spring allergy tips! From Dr Bailey

DC in spring is a cornucopia of beautiful cherry blossom trees and with the iconic flowers come lively events and sakura cocktails—but also the need for nasal spray. While the city celebrates with pink festivals and pink accessories, if you suffer from allergies, you might be on-theme with a pink ...

02/17/2024

Although it is snowing, the past few weeks with warmer temperatures and longer day light has triggered TREE pollens to begin releasing into the air. Be sure to follow your allergy action plan.

02/17/2024

Xolair is now FDA approved for patients with IgE mediated Food Allergy to help reduce anaphylaxis due to accidental exposure to a Food allergen.

Discover the latest news about our company, our products, our policies, and our people.

01/26/2024

Dupixent which is a biologic approved for ECZEMA, EOE, ASTHMA, NASAL POLYPS AND PURIGO NODULARIS just received FDA approval down to 1yr of age for treating EOE!

Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE) Approval based on Phase 3 EoE KIDS trial showing a greater...

12/21/2023

Our office will be closed Dec 25-Jan1. Re-opening on Jan 2. Happy Safe Holidays.

12/21/2023

FDA Grants Priority Review to Xolair (omalizumab) for Children and Adults With Food Allergies Based on Positive National Institutes of Health Phase III Study Results

If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure

Discover the latest news about our company, our products, our policies, and our people.